Stem cells Archives

News and Trends 13 Dec 2016

European Pharma closes 2016 by launching new Biotech Startups

Big pharma is already head on starting 2017 with a bang. Pfizer and Bayer are launching US-based startups in oncolytic virus and stem cell therapies. Pharma is wrapping up 2016 by investing in a pair of new ventures. Bayer and Versant have invested $225M to launch BlueRock Therapeutics, which will focus on CNS and cardiovascular diseases. This comes […]

December 13, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 1 Dec 2016

Evotec gets hold of CRISPR in a new Partnership with Merck

Evotec teamed up with Merck to boost its drug discovery services with CRISPR, entering the battlefield for the patent behind the discovery of the century. Apart from being a pioneer in the translation of research from academia to the clinic, Evotec is a successful CRO with top-level partners including Bayer, Roche, Sanofi, Boehringer Ingelheim and Takeda. The German company is […]

December 1, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Nov 2016

This Company joins a Tech Initiative to Repair the Heart with Stem Cells

Eppendorf joins a Horizon 2020 consortium to support bioreactor development for stem cell cultivation for heart attack patients. Stem cells have huge potential to treat or even cure a wide variety of medical conditions. Efforts to mitigate damage after a heart attack with stem cells are making a lot of progress. Researchers have successfully grown […]

November 23, 2016 - 4 minutesmins - By External Contributor

News and Trends 8 Nov 2016

These companies want to use Stem Cells to improve Drug Safety

Axiogenesis and Metrion Biosciences will use stem cells to improve preclinical neurotoxicity and cardiac safety testing, a feat that can significantly reduce the time and cost of drug discovery and clinical development. Axiogenesis is a Biotech from Cologne, Germany, that develops cell lines derived from induced pluripotent stem cells (iPSCs) for preclinical applications. The company […]

November 8, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 1 Sep 2016

Infographic: How Cancer Starts & How It Chooses Organs

Here’s a neat infographic from Cancer Research UK summarizing a new Cell report from UK researchers that describes how conditions build to trigger cancer. This information would help to explain the greater vulnerability of certain organs to tumors compared to others. The team, headed by Richard James Gilbertson, demonstrated that while cells may start with equal carcinogenic risk, tumor […]

September 1, 2016 - 1 minutemin - By Evelyn Warner

News and Trends 3 Aug 2016

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position even further by presenting good results from a Phase III of its stem cell therapy (Cx601) treating Crohn’s disease. UPDATE (article originally published on 24/8/2015): TiGenix’s Phase III results were now published in The Lancet. Julián Panés, the global coordinator […]

August 3, 2016 - 3 minutesmins - By Philip Hemme

molmed graft host disease zalmoxis leukemia

News and Trends 28 Jun 2016

Will the Leading Italian Biotech soon have its First Cell therapy on the Market?

MolMed has received conditional market approval for Zalmoxis, an ex vivo genetically engineered cell therapy that stops immune rejection of transplanted hematopoietic stem cells. This is a big step forward in a key treatment for blood cancers. A transplant of hematopoietic stem cells (cells that give origin to blood cells) is often used as part of treatments for […]

June 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

oxstem regenerative medicine stem cell leukemia

News and Trends 12 May 2016

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

OxStem’s strategy for stem cells therapy inside the body could have a big impact in regenerative medicine – and it has raised €21.4M, a record for a UK spin-out. A spin-out of Oxford University, OxStem is developing cell programming therapies that could treat a range of usually age-related conditions – dementia, heart failure, macular degeneration, […]

May 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 23 Oct 2015

Biotech of the week: Genenta Biosciences, a Novel Gene Therapies from Italy

This week we depart from East Germany and head south, through both Liechtenstein and Switzerland to the northern region of Italy, Lombardy. Here we arrive in Italy’s second largest city, Milan. This city is the center of fashion, Italian cuisine and is home to Da Vinci’s, ‘The Last Supper’ however, it is also home […]

October 23, 2015 - 2 minutesmins - By Philip Hemme

Karolinska Institutet Science Park stem cells

News and Trends 20 Oct 2015

First-ever in utero Stem Cell Trial to be conducted by Karolinska Institutet

The Karolisnka Institutet (Sweden) is ready to make History by conducting the first study involving the transplantation of stem cells into unborn babies. The treatment aims to strengthen the bone by producing collagen in infants with the brittle-bone disease Osteogenesis imperfecta in utero. The study is to be coordinated by the Karolinska Institute but to […]

October 20, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 13 Oct 2015

Why can’t Novartis Commit to the Israeli Biotech Scene?

Novartis, the Swiss Acquisition-Giant from Basel, has once again taken bought a small chunk of shares from the Israel biotech scene for only $15M (2.5%), instead of making a final solid purchase. The Jerusalem biotech Gamida Cell, which has a stem-cell therapies for hematological diseases (leukemia and various types of anemia), was underwhelmed a second […]

October 13, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 2 Oct 2015

Biotech of the week: Cell2b, the Promising Portuguese Cell Therapy Biotech

As it’s a new month, we thought we would try something a little different on Labiotech.eu. Every week we are going to showcase a company of our choice found on our map. The goal is to keep everybody up to date on all the various biotech and pharma companies that are found throughout Europe. This week […]

October 2, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Stem cells

European Pharma closes 2016 by launching new Biotech Startups

Evotec gets hold of CRISPR in a new Partnership with Merck

This Company joins a Tech Initiative to Repair the Heart with Stem Cells

These companies want to use Stem Cells to improve Drug Safety

Infographic: How Cancer Starts & How It Chooses Organs

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Will the Leading Italian Biotech soon have its First Cell therapy on the Market?

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

Biotech of the week: Genenta Biosciences, a Novel Gene Therapies from Italy

First-ever in utero Stem Cell Trial to be conducted by Karolinska Institutet

Why can’t Novartis Commit to the Israeli Biotech Scene?

Biotech of the week: Cell2b, the Promising Portuguese Cell Therapy Biotech

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!